Welcome to the Fall 2024 Notable New Drugs Report
New treatments target relatively small, hard-to-treat patient populations with big drug spend.
This edition of the report showcases:
- A first-in-class treatment for both A and B hemophilia which can reduce the frequency of bleeding episodes.
- A new addition to standard breast cancer therapy with improved outcomes for people with HR-positive breast cancer.
- A new drug to treat a rare congenital heart disease can reduce the risk of death by 57%.
Related healthcare insights
Thought leaders discuss the intentional vigilance needed to overcome obstacles impeding better access to healthcare for all.
Learn from Optum Rx thought leaders how access, affordability and transparency have become imperatives for pharmacy benefit management.
E-book
This is your employer guide to reducing your healthcare spending.